Cargando…
Pharmacokinetics of single and repeated oral doses of pregabalin oral solution formulation in cats
The study was designed to determine the pharmacokinetic profile and bioavailability of a novel pregabalin 50 mg/ml oral solution formulation (Bonqat(®), Orion Corporation Orion Pharma) in 6 healthy laboratory cats. The cats received pregabalin as single oral doses of 2.5, 5, and 7.5 mg/kg, dose 5 mg...
Autores principales: | Lamminen, Terttu, Doedée, Anne, Hyttilä‐Hopponen, Minja, Kaskinoro, Janne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545034/ https://www.ncbi.nlm.nih.gov/pubmed/35466408 http://dx.doi.org/10.1111/jvp.13061 |
Ejemplares similares
-
Pharmacokinetics of Single-Dose Oral Pregabalin Administration in Normal Cats
por: Esteban, Michaela A., et al.
Publicado: (2018) -
Efficacy of a Single Dose of Pregabalin on Signs of Anxiety in Cats During Transportation—A Pilot Study
por: Lamminen, Terttu, et al.
Publicado: (2021) -
Pregabalin Alleviates Anxiety and Fear in Cats during Transportation and Veterinary Visits—A Clinical Field Study
por: Lamminen, Terttu, et al.
Publicado: (2023) -
Pharmacokinetics and bioequivalence of two cyclosporine oral solution formulations in cats
por: Yang, Yuxin, et al.
Publicado: (2022) -
Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats
por: Roberts, E S, et al.
Publicado: (2014)